Korean physicians’ policies for postoperative surveillance of colorectal cancer
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: We explored Korean physicians’ policies for surveillance of colorectal cancer (CRC) after curative surgery. Methods: Web-based self-report questionnaires were developed. Invitations to participate were emailed to physicians who diagnosed and treated CRC from October 1 to November 15, 2015. The questionnaire consisted of the role doctors played in the surveillance, examination of surveillance, and duration of postoperative surveillance according to CRC stage or primary site of the cancer. Results: Ninety-one physicians participated in the online survey, and 78 completed the survey. Sixty-seven participants (13%) answered “up to 5 years” for stage I surveillance duration; and 11 (13%) responded with a duration of > 5 years for stage I. A total of 61 (75%) responded with a surveillance duration of up to 5 years for stage II; and 19 (24%) responded with a duration of > 5 years for stage II. Sixty-seven (97%) and 61 (91%) physicians monitored patients with stage II/III every 3 or 6 months by laboratory examination and by abdominopelvic computed tomography scan for the first year, respectively. A total of 43 (53%) responded with a surveillance duration of up to 5 years for stage IV; and 46 (46%) responded with a duration of > 5 years for stage IV after curative resection. Conclusions: Korean physicians mostly followed up CRC using intensive postoperative surveillance. In preference to monitoring over a comparatively shorter period of time, the physicians tended to prefer monitoring patients post-operatively over a > 5 year period, particularly in cases of advanced-stage CRC.
Abstract
Background/Aims: We explored Korean physicians’ policies for surveillance of colorectal cancer (CRC) after curative surgery. Methods: Web-based self-report questionnaires were developed. Invitations to participate were emailed to physicians who diagnosed and treated CRC from October 1 to November 15, 2015. The questionnaire consisted of the role doctors played in the surveillance, examination of surveillance, and duration of postoperative surveillance according to CRC stage or primary site of the cancer. Results: Ninety-one physicians participated in the online survey, and 78 completed the survey. Sixty-seven participants (13%) answered “up to 5 years” for stage I surveillance duration; and 11 (13%) responded with a duration of > 5 years for stage I. A total of 61 (75%) responded with a surveillance duration of up to 5 years for stage II; and 19 (24%) responded with a duration of > 5 years for stage II. Sixty-seven (97%) and 61 (91%) physicians monitored patients with stage II/III every 3 or 6 months by laboratory examination and by abdominopelvic computed tomography scan for the first year, respectively. A total of 43 (53%) responded with a surveillance duration of up to 5 years for stage IV; and 46 (46%) responded with a duration of > 5 years for stage IV after curative resection. Conclusions: Korean physicians mostly followed up CRC using intensive postoperative surveillance. In preference to monitoring over a comparatively shorter period of time, the physicians tended to prefer monitoring patients post-operatively over a > 5 year period, particularly in cases of advanced-stage CRC.
참고문헌 (15)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- Primrose JN, "Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial", JAMA, 311, pp.263~270 (2014)[DOI]
- Rodriguez-Moranta F, "Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial", J Clin Oncol, 24, pp.386~393 (2006)[DOI]
- Sargent D, "Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials", J Clin Oncol, 27, pp.872~877 (2009)[DOI]
- Cho YB, "Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection", Dis Colon Rectum, 50, pp.1204~1210 (2007)[DOI]
- Pita-Fernandez S, "Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis", Ann Oncol, 26, pp.644~656 (2015)[DOI]
- Glimelius B, "Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 24(Suppl 6), pp.vi81~vi88 (2013)
- Labianca R, "Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 24(Suppl 6), pp.vi64~vi72 (2013)
- Meyerhardt JA, "Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement", J Clin Oncol, 31, pp.4465~4470 (2013)[DOI]
- [URL]
- [URL]
- Eisenberg B, "Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients", Cancer, 49, pp.1131~1134 (1982)[DOI]
- 신애선, "Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009", Cancer Research and Treatment, 44(4), pp.219~226 (2012), 대한암학회[DOI]
- Seo SI, "Comparison of recurrence patterns between <TEX>$\leq$<", TEX>5 years and >5 years after curative operations in colorectal cancer patients, 2013, pp.108, 9~13
- Donadon M, "New paradigm in the management of liver-only metastases from colorectal cancer", Gastrointest Cancer Res, 1, pp.20~27 (2007)